Over the past few days, as the rest of the stock market melted down, a revolution has been quietly brewing in the market for ...

The company wants to create two focused companies dedicated to driving current and future value in their respective ...

As it gets harder to offer compounded GLP-1s, many telehealth companies are pivoting to hormone replacement therapy.

CordenPharma, a CDMO focused on peptides and peptide-based therapeutics, announced a partnership with Viking Therapeutics. The two companies will work together to ensure the production of Viking’s GLP ...

The GLP-1 weight loss market is a massive one ... While analysts were hoping to see weight loss of up to 25%, the company ...

Terns Pharmaceuticals is a small-cap biotech with a couple of weight loss candidates in its pipeline. The stock's price ...

Eli Lilly (LLY) believes its experimental weight-loss pill could make GLP-1 treatments more accessible worldwide.

Outsourcing Facilities Association and North American Custom Laboratories allege the FDA removed semaglutide from its ...

Drugs like Ozempic have a positive impact on weight loss, though only for a short period, with long-term health implications ...